Biodesix, Inc. Company Contacts

Biodesix, Inc.

https://www.biodesix.com
A leading diagnostic solutions company with five Medicare-covered tests for the lung cancer (oncology) healthcare continuum. Partnering with BioPharma companies with our unique portfolio of patented technologies, science, and processes. #proteomics #genomics #liquidbiopsy #bdsx #biodesix #lungcancer #biopharma #biotech #lifesciences #diagnostics... Read More
Contacts

Country

United States

City

Louisville

Headquarters

Louisville, Colorado

Profile

Founded

2005

Industry

Biotechnology Research

Size

201 - 500

Specialties

Molecular Diagnostics, Predictive, Prognostic and Mutation Tests, Companion Diagnostics, Mass Spectrometry Analysis of Biological Samples, oncology, lung cancer, lung disease, cancer diagnostics, biomarkers, liquid biopsy, ddPCR, Non-Small Cell Lung Cancer, Lung Nodules, Nodule Management, Proteomics, Artificial Intelligence, Genomic Testing, Clinical Trials, Biopharma Services, genomics, multi-omics

Funding

Total Rounds

22

Last Round

Thu Apr 04 2024

Last Round Series

Post IPO equity

Last Round Raised

$ 55,000,000